Myriad Genetics Inc (MYGN)
Healthcare
Diagnostics & Research
3.00 $
+5.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Myriad Genetics Inc (MYGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 639 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,149 | 1,147 | 1,111 | 1,085 | 1,081 | 1,028 | 1,006 | 677 | 728 | 707 | 674 | 639 | |
| 265 | 314 | 290 | 292 | 293 | 298 | 287 | 284 | 345 | 333 | 313 | 289 | |
| 76 | 132 | 97 | 92 | 100 | 102 | 92 | 74 | 145 | 150 | 124 | 115 | |
| 86 | 141 | 104 | 97 | 100 | 102 | 92 | 74 | 145 | 150 | 124 | 115 | |
| 115 | 114 | 118 | 118 | 126 | 121 | 120 | 137 | 118 | 115 | 124 | 110 | |
| 25 | 22 | 25 | 26 | 26 | 28 | 28 | 29 | 32 | 31 | 28 | 31 | |
| 287 | 287 | 287 | 286 | 286 | 286 | 286 | 52 | 52 | 52 | 47 | 47 | |
| 357 | 350 | 341 | 320 | 313 | 262 | 258 | 170 | 163 | 153 | 146 | 139 | |
| 466 | 363 | 351 | 345 | 350 | 327 | 301 | 289 | 355 | 339 | 336 | 335 | |
| 209 | 156 | 146 | 149 | 154 | 164 | 151 | 200 | 148 | 134 | 130 | 131 | |
| 18 | 16 | 14 | 13 | 14 | 13 | 11 | 68 | 7.9 | 6.9 | 7.1 | 7.3 | |
| 34 | 26 | 33 | 9.0 | 30 | 32 | 28 | 31 | 32 | 30 | 33 | 30 | |
| 39 | 39 | 39 | 39 | 39 | 40 | 59 | – | 120 | 120 | 120 | – | |
| 683 | 783 | 760 | 741 | 732 | 701 | 705 | 388 | 373 | 368 | 337 | 304 | |
| -598 | -630 | -656 | -692 | -714 | -757 | -757 | -1,087 | -1,115 | -1,123 | -1,157 | -1,200 | |
| 82 | 86 | 90 | 91 | 91 | 91 | 91 | 93 | 93 | 93 | 94 | 95 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.